Adopted neoplastic cells and the consequences of their existence
A new research perspective titled "Adopted neoplastic cells and the consequences of their existence" has been published in Oncotarget.
Aug 29, 2023
0
22
A new research perspective titled "Adopted neoplastic cells and the consequences of their existence" has been published in Oncotarget.
Aug 29, 2023
0
22
Two oral drugs, molnupiravir and paxlovid (nirmatrelvir/ritonavir), provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission ...
Aug 9, 2023
0
2
Gait-related disturbances adversely affect the quality of life of patients with Parkinson's disease (PD), a condition affecting millions worldwide. Although various pharmacological, surgical, and rehabilitative treatments ...
Aug 8, 2023
0
4
Pelvic pain in women with endometriosis is attributed to neuroinflammation. Researchers have investigated biochemical mediators of endometriosis-associated pelvic pain to provide a foundation to identify new drugs to improve ...
Aug 3, 2023
0
1
A new research paper was published in Oncotarget, titled "The uncharacterized transcript KIAA0930 confers a cachexic phenotype on cancer cells."
Jul 26, 2023
0
1
A new research paper was published in Oncotarget, titled, "Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells."
Jul 24, 2023
0
9
A new research perspective was published in Oncotarget, titled "Deciphering the mechanisms of action of progesterone in breast cancer."
Jul 10, 2023
0
0
A new editorial paper titled "Decoding the mechanism behind MCL-1 inhibitors: A pathway to understanding MCL-1 protein stability" has been published in Oncotarget.
Jun 28, 2023
0
2
A new research paper has been published in the journalOncotarget entitled, "Diphenyl ditelluride anticancer activity and DNA topoisomerase I poisoning in human colon cancer HCT116 cells." Diphenyl ditelluride (DPDT) is an ...
Jun 26, 2023
0
1
A new research paper was published in Oncotarget, titled "G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis."
May 22, 2023
0
14